Cargando…
Leukocyte Counts, Myeloperoxidase, and Pregnancy-Associated Plasma Protein A as Biomarkers for Cardiovascular Disease: Towards a Multi-Biomarker Approach
We evaluated leukocyte counts and levels of CRP, fibrinogen, MPO, and PAPP-A in patients with stable and unstable angina pectoris, acute myocardial infarction, and healthy controls. All biomarkers were analyzed again after 6 months. Leukocyte counts and concentrations of fibrinogen, CRP, MPO, and PA...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003971/ https://www.ncbi.nlm.nih.gov/pubmed/21188207 http://dx.doi.org/10.1155/2010/726207 |
_version_ | 1782193932448301056 |
---|---|
author | Lobbes, M. B. I. Kooi, M. E. Lutgens, E. Ruiters, A. W. Lima Passos, V. Braat, S. H. J. G. Rousch, M. Ten Cate, H. van Engelshoven, J. M. A. Daemen, M. J. A. P. Heeneman, S. |
author_facet | Lobbes, M. B. I. Kooi, M. E. Lutgens, E. Ruiters, A. W. Lima Passos, V. Braat, S. H. J. G. Rousch, M. Ten Cate, H. van Engelshoven, J. M. A. Daemen, M. J. A. P. Heeneman, S. |
author_sort | Lobbes, M. B. I. |
collection | PubMed |
description | We evaluated leukocyte counts and levels of CRP, fibrinogen, MPO, and PAPP-A in patients with stable and unstable angina pectoris, acute myocardial infarction, and healthy controls. All biomarkers were analyzed again after 6 months. Leukocyte counts and concentrations of fibrinogen, CRP, MPO, and PAPP-A were significantly increased in patients with acute myocardial infarction. Leukocyte counts and concentrations of MPO were significantly increased in patients with unstable angina pectoris compared with controls. After 6 months, leukocyte counts and MPO concentrations were still increased in patients with acute myocardial infarction when compared to controls. Discriminant analysis showed that leukocyte counts, MPO, and PAPP-A concentrations classified study group designation for acute coronary events correctly in 83% of the cases. In conclusion, combined assessment of leukocyte counts, MPO, and PAPP-A was able to correctly classify acute coronary events, suggesting that this could be a promising panel for a multibiomarker approach to assess cardiovascular risk. |
format | Text |
id | pubmed-3003971 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-30039712010-12-23 Leukocyte Counts, Myeloperoxidase, and Pregnancy-Associated Plasma Protein A as Biomarkers for Cardiovascular Disease: Towards a Multi-Biomarker Approach Lobbes, M. B. I. Kooi, M. E. Lutgens, E. Ruiters, A. W. Lima Passos, V. Braat, S. H. J. G. Rousch, M. Ten Cate, H. van Engelshoven, J. M. A. Daemen, M. J. A. P. Heeneman, S. Int J Vasc Med Clinical Study We evaluated leukocyte counts and levels of CRP, fibrinogen, MPO, and PAPP-A in patients with stable and unstable angina pectoris, acute myocardial infarction, and healthy controls. All biomarkers were analyzed again after 6 months. Leukocyte counts and concentrations of fibrinogen, CRP, MPO, and PAPP-A were significantly increased in patients with acute myocardial infarction. Leukocyte counts and concentrations of MPO were significantly increased in patients with unstable angina pectoris compared with controls. After 6 months, leukocyte counts and MPO concentrations were still increased in patients with acute myocardial infarction when compared to controls. Discriminant analysis showed that leukocyte counts, MPO, and PAPP-A concentrations classified study group designation for acute coronary events correctly in 83% of the cases. In conclusion, combined assessment of leukocyte counts, MPO, and PAPP-A was able to correctly classify acute coronary events, suggesting that this could be a promising panel for a multibiomarker approach to assess cardiovascular risk. Hindawi Publishing Corporation 2010 2010-05-30 /pmc/articles/PMC3003971/ /pubmed/21188207 http://dx.doi.org/10.1155/2010/726207 Text en Copyright © 2010 M. B. I. Lobbes et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Study Lobbes, M. B. I. Kooi, M. E. Lutgens, E. Ruiters, A. W. Lima Passos, V. Braat, S. H. J. G. Rousch, M. Ten Cate, H. van Engelshoven, J. M. A. Daemen, M. J. A. P. Heeneman, S. Leukocyte Counts, Myeloperoxidase, and Pregnancy-Associated Plasma Protein A as Biomarkers for Cardiovascular Disease: Towards a Multi-Biomarker Approach |
title | Leukocyte Counts, Myeloperoxidase, and Pregnancy-Associated Plasma Protein A as Biomarkers for Cardiovascular Disease: Towards a Multi-Biomarker Approach |
title_full | Leukocyte Counts, Myeloperoxidase, and Pregnancy-Associated Plasma Protein A as Biomarkers for Cardiovascular Disease: Towards a Multi-Biomarker Approach |
title_fullStr | Leukocyte Counts, Myeloperoxidase, and Pregnancy-Associated Plasma Protein A as Biomarkers for Cardiovascular Disease: Towards a Multi-Biomarker Approach |
title_full_unstemmed | Leukocyte Counts, Myeloperoxidase, and Pregnancy-Associated Plasma Protein A as Biomarkers for Cardiovascular Disease: Towards a Multi-Biomarker Approach |
title_short | Leukocyte Counts, Myeloperoxidase, and Pregnancy-Associated Plasma Protein A as Biomarkers for Cardiovascular Disease: Towards a Multi-Biomarker Approach |
title_sort | leukocyte counts, myeloperoxidase, and pregnancy-associated plasma protein a as biomarkers for cardiovascular disease: towards a multi-biomarker approach |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003971/ https://www.ncbi.nlm.nih.gov/pubmed/21188207 http://dx.doi.org/10.1155/2010/726207 |
work_keys_str_mv | AT lobbesmbi leukocytecountsmyeloperoxidaseandpregnancyassociatedplasmaproteinaasbiomarkersforcardiovasculardiseasetowardsamultibiomarkerapproach AT kooime leukocytecountsmyeloperoxidaseandpregnancyassociatedplasmaproteinaasbiomarkersforcardiovasculardiseasetowardsamultibiomarkerapproach AT lutgense leukocytecountsmyeloperoxidaseandpregnancyassociatedplasmaproteinaasbiomarkersforcardiovasculardiseasetowardsamultibiomarkerapproach AT ruitersaw leukocytecountsmyeloperoxidaseandpregnancyassociatedplasmaproteinaasbiomarkersforcardiovasculardiseasetowardsamultibiomarkerapproach AT limapassosv leukocytecountsmyeloperoxidaseandpregnancyassociatedplasmaproteinaasbiomarkersforcardiovasculardiseasetowardsamultibiomarkerapproach AT braatshjg leukocytecountsmyeloperoxidaseandpregnancyassociatedplasmaproteinaasbiomarkersforcardiovasculardiseasetowardsamultibiomarkerapproach AT rouschm leukocytecountsmyeloperoxidaseandpregnancyassociatedplasmaproteinaasbiomarkersforcardiovasculardiseasetowardsamultibiomarkerapproach AT tencateh leukocytecountsmyeloperoxidaseandpregnancyassociatedplasmaproteinaasbiomarkersforcardiovasculardiseasetowardsamultibiomarkerapproach AT vanengelshovenjma leukocytecountsmyeloperoxidaseandpregnancyassociatedplasmaproteinaasbiomarkersforcardiovasculardiseasetowardsamultibiomarkerapproach AT daemenmjap leukocytecountsmyeloperoxidaseandpregnancyassociatedplasmaproteinaasbiomarkersforcardiovasculardiseasetowardsamultibiomarkerapproach AT heenemans leukocytecountsmyeloperoxidaseandpregnancyassociatedplasmaproteinaasbiomarkersforcardiovasculardiseasetowardsamultibiomarkerapproach |